Suppr超能文献

[芴甲醇的合成及其抗疟活性]

[Synthesis and antimalarial activities of fluorenemethanols].

作者信息

Deng R X, Zhong J X, Zhao D C, Zhang H B, Sheng X Y, Ding D B, Yang J D

机构信息

Institute of Microbiology and Epidemiology, Military Academy of Medical Sciences, Beijing 100071.

出版信息

Yao Xue Xue Bao. 1997 Nov;32(11):874-8.

Abstract

For the purpose of improving the oral antimalarial activities of the fluorenemethanols (reported by us in previous articles) which were less effective by oral than by subcutaneous administration, 24 alpha-(alkylaminomethyl)-2, 7-dichloro-9-substituted benzylidene-4-fluorenemethanols (III) were synthesized. The results of preliminary screenings demonstrated that five compounds (No. 1-4, 8) exhibited significant antimalarial activities against Plasmodium berghei NK65 strain in mice by oral administration, at dose of 6.25 mg.kg-1.d-1 x 3 with suppressive rate of 100%. Further evaluation of these 5 compounds showed that 4 of them (No. 1-4) were superior to chloroquine in parallel tests, their ED50 and ED90 were 1.0, 1.6; 0.6, 0.9; 0.7, 1.5 and 0.8, 1.6 mg.kg-1.d-1 x 3 respectively, while the ED50 and ED90 of chloroquine were 1.9 and 2.9 mg.kg-1. d-1 x 3 respectively; one compound (No 8) was equal to chloroquine, its ED50 and ED90 were 1.5 and 3.2 mg.kg-1.d-1 x 3 respectively. Further assessment of these 4 compounds are in progress.

摘要

为提高芴甲醇类化合物(我们之前的文章中有报道)的口服抗疟活性(该类化合物口服效果不如皮下给药),合成了24α-(烷基氨甲基)-2,7-二氯-9-取代亚苄基-4-芴甲醇(III)。初步筛选结果表明,5种化合物(编号1 - 4、8)在剂量为6.25 mg·kg⁻¹·d⁻¹×3时,对小鼠伯氏疟原虫NK65株口服给药显示出显著的抗疟活性,抑制率达100%。对这5种化合物的进一步评估表明,其中4种(编号1 - 4)在平行试验中优于氯喹,它们的ED50和ED90分别为1.0、1.6;0.6、0.9;0.7、1.5和0.8、1.6 mg·kg⁻¹·d⁻¹×3,而氯喹的ED50和ED90分别为1.9和2.9 mg·kg⁻¹·d⁻¹×3;一种化合物(编号8)与氯喹相当,其ED50和ED90分别为1.5和3.2 mg·kg⁻¹·d⁻¹×3。对这4种化合物的进一步评估正在进行中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验